SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-22-009485
Filing Date
2022-03-10
Accepted
2022-03-10 08:19:10
Documents
89
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K achv-10k_20211231.htm   iXBRL 10-K 4052024
2 EX-21.1 achv-ex211_7.htm EX-21.1 2045
3 EX-23.1 achv-ex231_11.htm EX-23.1 2665
4 EX-31.1 achv-ex311_10.htm EX-31.1 8189
5 EX-32.1 achv-ex321_6.htm EX-32.1 3803
  Complete submission text file 0001564590-22-009485.txt   14115806

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA achv-20211231.xsd EX-101.SCH 90520
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE achv-20211231_cal.xml EX-101.CAL 59475
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE achv-20211231_def.xml EX-101.DEF 337556
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE achv-20211231_lab.xml EX-101.LAB 652663
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achv-20211231_pre.xml EX-101.PRE 513829
83 EXTRACTED XBRL INSTANCE DOCUMENT achv-10k_20211231_htm.xml XML 2804037
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 033-80623 | Film No.: 22727509
SIC: 2835 In Vitro & In Vivo Diagnostic Substances